NGEN compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

NGENNervgen Pharma Corp.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

NGENNervgen Pharma Corp.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NGEN 0

None

Shared 0

No disclosed counterparties: NGEN.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Role chip = supplier or customerSource: SEC EDGAR

NGENNervgen Pharma Corp.

1.31▼−2.96%· post 1.30· delayed

Mkt cap$97.6MRevenue—Revenue—

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,360.68· delayed

After hoursNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 5 '26delayed

NGENNervgen Pharma Corp.

LLYELI Lilly & Co

1.31▼−2.96%post 1.30delayed

Price

1,371.32▼−3.29%post 1,360.68delayed

$97.6M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

NGEN1.31▼−2.96%vsLLY1,371.32▼−3.29%After hoursNov 5 '26delayed